Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
147.6 USD | +1.28% | -0.08% | -5.96% |
01:47pm | WHO says wider alert on contaminated J&J cough syrup 'likely' | RE |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Financials (USD)
Sales 2024 * | 88.39B | Sales 2025 * | 90.82B | Capitalization | 351B |
---|---|---|---|---|---|
Net income 2024 * | 22.31B | Net income 2025 * | 23B | EV / Sales 2024 * | 3.89 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.63 x |
P/E ratio 2024 * |
16.7
x | P/E ratio 2025 * |
15.7
x | Employees | 131,900 |
Yield 2024 * |
3.31% | Yield 2025 * |
3.46% | Free-Float | 77.1% |
Latest transcript on Johnson & Johnson
1 day | +0.62% | ||
1 week | -0.44% | ||
Current month | -7.16% | ||
1 month | -5.98% | ||
3 months | -9.16% | ||
6 months | -3.58% | ||
Current year | -6.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 215 M€ | +12.77% | - | |
12.91% | 18 M€ | +1.40% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 147.4 | +1.13% | 5 039 855 |
24-04-18 | 145.7 | +0.67% | 9,887,704 |
24-04-17 | 144.8 | +0.22% | 9,378,059 |
24-04-16 | 144.4 | -2.13% | 12,774,859 |
24-04-15 | 147.6 | +0.05% | 8,502,266 |
Delayed Quote Nyse, April 19, 2024 at 12:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.30% | 351B | |
+25.27% | 672B | |
+24.08% | 550B | |
+15.04% | 317B | |
+7.19% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-10.26% | 144B | |
-7.30% | 141B | |
-3.20% | 113B |
- Stock Market
- Equities
- JNJ Stock